全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

迟发型鸟氨酸氨甲酰基转移酶缺乏症:1例女性患儿报告及文献回顾
Late-Onset Ornithine Transcarbamylase Deficiency: A Case Report of a Female Pediatric Patient and Literature Review

DOI: 10.12677/acrp.2025.131001, PP. 1-4

Keywords: 鸟氨酸氨甲酰基转移酶缺乏症,高氨血症,肝移植,基因治疗
Ornithine Transcarbamylase Deficiency (OTCD)
, Hyperammonemia, Liver Transplantation, Gene Therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

鸟氨酸氨甲酰基转移酶缺乏症(Ornithine Transcarbamylase Deficiency, OTCD)是尿素循环障碍中最常见的X连锁隐性遗传病。该病因高氨血症引发进行性脑损伤及肝功能异常,临床表现存在显著个体差异。本文报告1例2岁6个月女性迟发型患儿,以反复呕吐、性格改变及肝功能异常为特征表现,经血浆氨检测、串联质谱、基因测序确诊为OTCD。通过低蛋白饮食、降氨治疗及后续肝移植干预,患儿病情得到有效控制。本病例提示,对于不明原因呕吐伴高氨血症的婴幼儿,需高度警惕尿素循环障碍可能,早期开展血氨筛查及基因检测有助于及时诊断。本研究通过病例分析结合文献复习,为临床识别及管理OTCD提供参考。
Ornithine Transcarbamylase Deficiency (OTCD), the most prevalent X-linked recessive disorder in urea cycle defects, induces progressive neurological damage and hepatic dysfunction through hyperammonemia, with marked individual variations in clinical manifestations. This study presents a 2-year-and-6-month-old female patient with late-onset OTCD, characterized by recurrent vomiting, personality changes, and abnormal liver function. Diagnosis was confirmed through plasma ammonia measurement, tandem mass spectrometry, and genetic sequencing. Effective management was achieved via low-protein diet, ammonia-lowering therapy, and subsequent liver transplantation. This case underscores the necessity of suspecting urea cycle disorders in infants with unexplained vomiting accompanied by hyperammonemia, emphasizing that early plasma ammonia screening and genetic testing are crucial for timely diagnosis. Through comprehensive case analysis and literature review, this study provides clinical insights for the identification and management of OTCD.

References

[1]  Brassier, A., Gobin, S., Arnoux, J.B., Valayannopoulos, V., Habarou, F., Kossorotoff, M., et al. (2015) Long-Term Outcomes in Ornithine Transcarbamylase Deficiency: A Series of 90 Patients. Orphanet Journal of Rare Diseases, 10, Article No. 58.
https://doi.org/10.1186/s13023-015-0266-1
[2]  孔元原, 韩连书, 杨艳玲, 等. 鸟氨酸氨甲酰转移酶缺乏症诊治专家共识[J]. 浙江大学学报(医学版), 2020, 49(5): 539-547.
[3]  郝虎. 鸟氨酸氨甲酰转移酶缺乏症诊断与治疗[J]. 中国实用儿科杂志, 2021, 36(10): 744-748.
[4]  Mukhtar, A., Dabbous, H., El Sayed, R., Aboulfetouh, F., Bahaa, M., Abdelaal, A., et al. (2013) A Novel Mutation of the Ornithine Transcarbamylase Gene Leading to Fatal Hyperammonemia in a Liver Transplant Recipient. American Journal of Transplantation, 13, 1084-1087.
https://doi.org/10.1111/ajt.12146
[5]  Berraondo, P., Martini, P.G.V., Avila, M.A. and Fontanellas, A. (2019) Messenger RNA Therapy for Rare Genetic Metabolic Diseases. Gut, 68, 1323-1330.
https://doi.org/10.1136/gutjnl-2019-318269
[6]  Zhou, J., Liang, S., Yin, L., Frassetto, A., Graham, A., White, R., et al. (2025) Characterization of a Novel Conditional Knockout Mouse Model to Assess Efficacy of Mrna Therapy in the Context of Severe OTC Deficiency. Molecular Therapy, 33, 1197-1212.
https://doi.org/10.1016/j.ymthe.2025.01.010
[7]  Laemmle, A., Poms, M., Hsu, B., Borsuk, M., Rüfenacht, V., Robinson, J., et al. (2021) Aquaporin 9 Induction in Human IPSC‐Derived Hepatocytes Facilitates Modeling of Ornithine Transcarbamylase Deficiency. Hepatology, 76, 646-659.
https://doi.org/10.1002/hep.32247
[8]  Soria, L.R., Gurung, S., De Sabbata, G., Perocheau, D.P., De Angelis, A., Bruno, G., et al. (2020) Beclin‐1‐Mediated Activation of Autophagy Improves Proximal and Distal Urea Cycle Disorders. EMBO Molecular Medicine, 13, e13158.
https://doi.org/10.15252/emmm.202013158
[9]  Hallows, W.C., Yu, W., Smith, B.C., Devires, M.K., Ellinger, J.J., Someya, S., et al. (2011) Sirt3 Promotes the Urea Cycle and Fatty Acid Oxidation during Dietary Restriction. Molecular Cell, 41, 139-149.
https://doi.org/10.1016/j.molcel.2011.01.002
[10]  Horwich, A.L. (2011) Protein Folding in the Cell: An Inside Story. Nature Medicine, 17, 1211-1216.
https://doi.org/10.1038/nm.2468
[11]  Musunuru, K., Grandinette, S.A., Wang, X., et al. (2025) Patient-Specific in Vivo Gene Editing to Treat a Rare Genetic Disease. The New England Journal of Medicine.
[12]  Sacchetto, C., Peretto, L., Baralle, F., Maestri, I., Tassi, F., Bernardi, F., et al. (2021) OTC Intron 4 Variations Mediate Pathogenic Splicing Patterns Caused by the c.386G > A Mutation in Humans and spfash Mice, and Govern Susceptibility to RNA-Based Therapies. Molecular Medicine, 27, Article No. 157.
https://doi.org/10.1186/s10020-021-00418-9

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133